huMST1 Mouse
제품명
huMST1 Mouse
제품 ID
C002070
품종 계통
C57BL/6NCya-Mst1tm1(hMST1)/Cya
Backgroud
C57BL/6NCya
상태
이 마우스 계통을 논문에서 사용할 경우, “huMST1 Mouse (카탈로그 번호 C002070)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
유전자명
유전자 별칭
MSP, HGFL, NF15S2, D3F15S2, DNF15S2
NCBI ID
염색체
Chr 3
MGI ID
Datasheet
품종 계통 설명
MST1 (Macrophage Stimulating 1), also known as hepatocyte growth factor-like protein (HGFL), is the natural ligand for the RON receptor tyrosine kinase. MST1 serves as a critical node connecting immune regulation and metabolic homeostasis. In tumor immunology, it shapes the immune landscape of the tumor microenvironment by regulating Treg stability, dendritic cell (DC) antigen presentation, macrophage polarization, and fundamental lymphocyte functions [1-2]. In metabolic diseases, it participates in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD), diabetes, and related complications through regulation of AMPK/SREBP-1c-mediated lipid metabolism signaling, mitophagy, and YAP signaling pathways [3-5].
The huMST1 mouse model is a humanized model generated using gene-editing technology, in which the mouse Mst1 genomic region was replaced with the corresponding human MST1 genomic sequence while retaining the murine signal peptide sequence. In tumor immunology, this model can be used to evaluate the regulatory effects of MST1 on the functions of CD8+ T cells and Treg cells, and to investigate MST1-mediated immune regulatory mechanisms and its interactions with the tumor microenvironment. In metabolic diseases, this model can be utilized to explore the pathogenic mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD), liver fibrosis, and diabetes, as well as the development of MST1-targeted therapeutics.
Reference
Zhou J, Li L, Wu B, Feng Z, Lu Y, Wang Z. MST1/2: Important regulators of Hippo pathway in immune system associated diseases. Cancer Lett. 2024 Apr 10;587:216736.
Du X, Wen J, Wang Y, Karmaus PWF, Khatamian A, Tan H, Li Y, Guy C, Nguyen TM, Dhungana Y, Neale G, Peng J, Yu J, Chi H. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018 Jun;558(7708):141-145.
Zhou T, Chang L, Luo Y, Zhou Y, Zhang J. Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. Redox Biol. 2019 Feb;21:101120. doi: 10.1016/j.redox.2019.101120. Epub 2019 Jan 23. Erratum in: Redox Biol. 2020 Jan;28:101299.
Wang K, Yang J, An Y, Wang J, Tan S, Xu H, Dong Y. MST1/2 regulates fibro/adipogenic progenitor fate decisions in skeletal muscle regeneration. Stem Cell Reports. 2024 Apr 9;19(4):501-514.
Wang J, Qi Z, Wu Y, Wang A, Liu Q, Zou F, Wang B, Qi S, Cao J, Hu C, Shi C, Liang Q, Wang L, Liu J, Wang W, Liu Q. Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus. Signal Transduct Target Ther. 2023 Apr 5;8(1):143.
변형 전략
The mouse Mst1 endogenous genomic region was replaced with the human MST1 genomic region. The murine signal peptide was preserved. The KI region may affect the expression of mouse Mir7088, while its effect on mouse Rnf123 remains unclear.
Figure 1. Gene editing strategy of huMST1 mice.
응용 분야
Investigate the role of MST1 in macrophage activation, regulation of inflammatory responses, and immune cell functions;
Explore the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD), liver fibrosis, and diabetes;
Develop MST1-targeted therapeutics.
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.